Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06565910
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-09
Brief Title:
Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty PENG
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for PENG Block on Post Operative Pain Management in Patients Undergoing Hip Arthroplasty a Prospective Randomized Single Blind Active Controlled Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PENG
Brief Summary:
The goal of this clinical trial is to study the analgesic effect of liposomal bupivacaine plus bupivacaine for Pericapsular Nerve Group PENG block in postoperative pain management following hip replacement surgery It will also assess the safety of liposomal bupivacaine for this purpose The main questions it aims to answer are
1 Is liposomal bupivacaine plus bupivacaine superior to ropivacaine in terms of analgesic efficacy duration of pain relief opioid consumption and patient satisfaction
2 What medical problems do participants encounter when using liposomal bupivacaine plus bupivacaine for PENG block in postoperative pain management following hip replacement surgery
Researchers will compare liposomal bupivacaine plus bupivacaine to ropivacaine a routinely used regional anesthetic in clinical practice to determine if liposomal bupivacaine plus bupivacaine is more effective for pain management following hip replacement surgery
Participants will
1 Receive liposomal bupivacaine plus bupivacaine or ropivacaine as a regional anesthetic for PENG block under ultrasound guidance
2 Undergo hip replacement surgery under spinal anesthesia
3 Have pain relief opioid analgesic consumption and incidence of complications assessed at multiple time points within 72 hours after surgery
1 Is liposomal bupivacaine plus bupivacaine superior to ropivacaine in terms of analgesic efficacy duration of pain relief opioid consumption and patient satisfaction
2 What medical problems do participants encounter when using liposomal bupivacaine plus bupivacaine for PENG block in postoperative pain management following hip replacement surgery
Researchers will compare liposomal bupivacaine plus bupivacaine to ropivacaine a routinely used regional anesthetic in clinical practice to determine if liposomal bupivacaine plus bupivacaine is more effective for pain management following hip replacement surgery
Participants will
1 Receive liposomal bupivacaine plus bupivacaine or ropivacaine as a regional anesthetic for PENG block under ultrasound guidance
2 Undergo hip replacement surgery under spinal anesthesia
3 Have pain relief opioid analgesic consumption and incidence of complications assessed at multiple time points within 72 hours after surgery
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None